questionsmedicales.fr
Structures de l'embryon
Feuillets embryonnaires
Feuillets embryonnaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Embryogenèse
Développement embryonnaire
Échographie
Imagerie par résonance magnétique
Anomalies congénitales
Tests génétiques
Malformations congénitales
Retard de développement
Imagerie médicale
Observation embryonnaire
Symptômes
5
Malformations congénitales
Troubles fonctionnels
Retard de croissance
Dysfonctionnement organique
Malformations visibles
Troubles internes
Anomalies congénitales
Développement infantile
Prévention
5
Alimentation équilibrée
Soins prénatals
Dépistage prénatal
Risques embryonnaires
Vaccinations
Infections congénitales
Stress maternel
Développement embryonnaire
Antécédents familiaux
Risques génétiques
Traitements
5
Chirurgie corrective
Thérapie génique
Nutrition prénatale
Soins prénatals
Efficacité des traitements
Anomalies détectées
Thérapies innovantes
Recherche médicale
Suivi médical
Évaluation des soins
Complications
5
Malformations graves
Décès néonatal
Complications tardives
Développement infantile
Maladies chroniques
Troubles du développement
Traitements médicaux
Chirurgie
Qualité de vie
Impact sur la santé
Facteurs de risque
5
Âge maternel
Antécédents familiaux
Toxines environnementales
Risques embryonnaires
Diabète gestationnel
Anomalies congénitales
Médicaments tératogènes
Développement embryonnaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Feuillets embryonnaires : Questions médicales les plus fréquentes",
"headline": "Feuillets embryonnaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Feuillets embryonnaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-24",
"dateModified": "2025-04-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Feuillets embryonnaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Structures de l'embryon",
"url": "https://questionsmedicales.fr/mesh/D004628",
"about": {
"@type": "MedicalCondition",
"name": "Structures de l'embryon",
"code": {
"@type": "MedicalCode",
"code": "D004628",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ectoderme",
"alternateName": "Ectoderm",
"url": "https://questionsmedicales.fr/mesh/D004475",
"about": {
"@type": "MedicalCondition",
"name": "Ectoderme",
"code": {
"@type": "MedicalCode",
"code": "D004475",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16.504.273"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Endoderme",
"alternateName": "Endoderm",
"url": "https://questionsmedicales.fr/mesh/D004707",
"about": {
"@type": "MedicalCondition",
"name": "Endoderme",
"code": {
"@type": "MedicalCode",
"code": "D004707",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16.504.407"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mésoderme",
"alternateName": "Mesoderm",
"url": "https://questionsmedicales.fr/mesh/D008648",
"about": {
"@type": "MedicalCondition",
"name": "Mésoderme",
"code": {
"@type": "MedicalCode",
"code": "D008648",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16.504.660"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Péricytes",
"alternateName": "Pericytes",
"url": "https://questionsmedicales.fr/mesh/D020286",
"about": {
"@type": "MedicalCondition",
"name": "Péricytes",
"code": {
"@type": "MedicalCode",
"code": "D020286",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16.504.660.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Somites",
"alternateName": "Somites",
"url": "https://questionsmedicales.fr/mesh/D019170",
"about": {
"@type": "MedicalCondition",
"name": "Somites",
"code": {
"@type": "MedicalCode",
"code": "D019170",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A16.504.660.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Feuillets embryonnaires",
"alternateName": "Germ Layers",
"code": {
"@type": "MedicalCode",
"code": "D005855",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Elizabeth R Gavis",
"url": "https://questionsmedicales.fr/author/Elizabeth%20R%20Gavis",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biology, Princeton University, Princeton, New Jersey, United States of America."
}
},
{
"@type": "Person",
"name": "Bernard K van der Veer",
"url": "https://questionsmedicales.fr/author/Bernard%20K%20van%20der%20Veer",
"affiliation": {
"@type": "Organization",
"name": "Laboratory for Stem Cell and Developmental Epigenetics, Department of Development and Regeneration, Katholieke Universiteit Leuven, 3000 Leuven, Belgium."
}
},
{
"@type": "Person",
"name": "Kian Peng Koh",
"url": "https://questionsmedicales.fr/author/Kian%20Peng%20Koh",
"affiliation": {
"@type": "Organization",
"name": "Laboratory for Stem Cell and Developmental Epigenetics, Department of Development and Regeneration, Katholieke Universiteit Leuven, 3000 Leuven, Belgium."
}
},
{
"@type": "Person",
"name": "Ulrich Technau",
"url": "https://questionsmedicales.fr/author/Ulrich%20Technau",
"affiliation": {
"@type": "Organization",
"name": "Department for Molecular Evolution and Development, Centre of Organismal Systems Biology, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria ulrich.technau@univie.ac.at."
}
},
{
"@type": "Person",
"name": "Patrick P L Tam",
"url": "https://questionsmedicales.fr/author/Patrick%20P%20L%20Tam",
"affiliation": {
"@type": "Organization",
"name": "Embryology Research Unit, Children's Medical Research Institute, and School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Multimodal imaging of essential tremor and dystonic tremor.",
"datePublished": "2022-10-25",
"url": "https://questionsmedicales.fr/article/36451353",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nicl.2022.103247"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lack of Familial Aggregation of the \"Essential Tremor-Plus\" Phenotype in Familial Essential Tremor.",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/35940165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000526278"
}
},
{
"@type": "ScholarlyArticle",
"name": "Essential tremor plus rest tremor: current concepts and controversies.",
"datePublished": "2022-06-07",
"url": "https://questionsmedicales.fr/article/35672518",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00702-022-02516-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "French validation of the Quality of life in Essential Tremor Questionnaire (QUEST) and the Essential Tremor Embarrassment Assessment (ETEA).",
"datePublished": "2023-09-19",
"url": "https://questionsmedicales.fr/article/37735016",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neurol.2023.03.030"
}
},
{
"@type": "ScholarlyArticle",
"name": "Distribution of rest tremor in patients with Essential Tremor: Does it lateralize with simple kinetic, postural, or intention tremors?",
"datePublished": "2022-07-31",
"url": "https://questionsmedicales.fr/article/35933821",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.parkreldis.2022.07.018"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Structures de l'embryon",
"item": "https://questionsmedicales.fr/mesh/D004628"
},
{
"@type": "ListItem",
"position": 3,
"name": "Feuillets embryonnaires",
"item": "https://questionsmedicales.fr/mesh/D005855"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Feuillets embryonnaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Feuillets embryonnaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Feuillets embryonnaires",
"description": "Comment identifier les feuillets embryonnaires ?\nQuels examens sont utilisés pour étudier les feuillets ?\nPeut-on détecter des anomalies des feuillets ?\nQuels signes indiquent des problèmes embryonnaires ?\nLes feuillets peuvent-ils être visualisés directement ?",
"url": "https://questionsmedicales.fr/mesh/D005855?mesh_terms=Essential+Tremor#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Feuillets embryonnaires",
"description": "Quels symptômes sont liés aux anomalies des feuillets ?\nLes anomalies des feuillets affectent-elles le développement ?\nComment les anomalies se manifestent-elles ?\nLes symptômes varient-ils selon le feuillet affecté ?\nLes symptômes sont-ils toujours présents à la naissance ?",
"url": "https://questionsmedicales.fr/mesh/D005855?mesh_terms=Essential+Tremor#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Feuillets embryonnaires",
"description": "Comment prévenir les anomalies des feuillets embryonnaires ?\nLe dépistage prénatal aide-t-il à prévenir les anomalies ?\nLes vaccinations sont-elles importantes pendant la grossesse ?\nLe stress maternel influence-t-il le développement embryonnaire ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D005855?mesh_terms=Essential+Tremor#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Feuillets embryonnaires",
"description": "Quels traitements existent pour les anomalies des feuillets ?\nPeut-on prévenir les anomalies des feuillets ?\nLes traitements sont-ils efficaces ?\nY a-t-il des traitements expérimentaux ?\nLes traitements nécessitent-ils un suivi ?",
"url": "https://questionsmedicales.fr/mesh/D005855?mesh_terms=Essential+Tremor#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Feuillets embryonnaires",
"description": "Quelles complications peuvent survenir avec des anomalies des feuillets ?\nLes complications sont-elles toujours visibles à la naissance ?\nLes anomalies des feuillets augmentent-elles le risque de maladies ?\nLes complications peuvent-elles être traitées ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D005855?mesh_terms=Essential+Tremor#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Feuillets embryonnaires",
"description": "Quels sont les facteurs de risque pour les anomalies des feuillets ?\nL'exposition à des toxines influence-t-elle le développement ?\nLes maladies maternelles affectent-elles le fœtus ?\nLe mode de vie maternel joue-t-il un rôle ?\nLes traitements médicaux peuvent-ils influencer le développement ?",
"url": "https://questionsmedicales.fr/mesh/D005855?mesh_terms=Essential+Tremor#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les feuillets embryonnaires ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'identification se fait par l'observation des couches cellulaires lors de l'embryogenèse."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour étudier les feuillets ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie et l'imagerie par résonance magnétique (IRM) sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anomalies des feuillets ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent être détectées par des tests génétiques et des échographies."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent des problèmes embryonnaires ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des malformations ou des retards de développement peuvent indiquer des problèmes."
}
},
{
"@type": "Question",
"name": "Les feuillets peuvent-ils être visualisés directement ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils sont généralement étudiés par des méthodes indirectes comme l'imagerie."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux anomalies des feuillets ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des malformations physiques et des troubles fonctionnels."
}
},
{
"@type": "Question",
"name": "Les anomalies des feuillets affectent-elles le développement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des retards de croissance et des dysfonctionnements organiques."
}
},
{
"@type": "Question",
"name": "Comment les anomalies se manifestent-elles ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent se manifester par des malformations visibles ou des troubles internes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le feuillet affecté ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque feuillet (ectoderme, mésoderme, endoderme) a des implications spécifiques."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents à la naissance ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certaines anomalies peuvent se développer plus tard dans l'enfance."
}
},
{
"@type": "Question",
"name": "Comment prévenir les anomalies des feuillets embryonnaires ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'évitement de substances nocives et des soins prénatals sont cruciaux."
}
},
{
"@type": "Question",
"name": "Le dépistage prénatal aide-t-il à prévenir les anomalies ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage permet d'identifier les risques et d'agir en conséquence."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes pendant la grossesse ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations protègent le fœtus contre des infections pouvant causer des anomalies."
}
},
{
"@type": "Question",
"name": "Le stress maternel influence-t-il le développement embryonnaire ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un stress élevé peut affecter le développement et augmenter le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'anomalies peuvent augmenter le risque pour le fœtus."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies des feuillets ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements varient de la chirurgie corrective à la thérapie génique selon l'anomalie."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies des feuillets ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent être prévenues par une bonne nutrition et des soins prénatals."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité dépend de la nature et de la gravité de l'anomalie détectée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des recherches sont en cours sur des thérapies innovantes pour certaines anomalies."
}
},
{
"@type": "Question",
"name": "Les traitements nécessitent-ils un suivi ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour évaluer l'évolution et ajuster les soins."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies des feuillets ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des malformations graves, des troubles fonctionnels et des décès néonatals."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles toujours visibles à la naissance ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines complications peuvent se manifester plus tard dans l'enfance."
}
},
{
"@type": "Question",
"name": "Les anomalies des feuillets augmentent-elles le risque de maladies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent prédisposer à des maladies chroniques ou à des troubles du développement."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être traitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées par des traitements médicaux ou chirurgicaux."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent avoir un impact significatif sur la qualité de vie de l'individu."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies des feuillets ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge maternel avancé, des antécédents familiaux et des infections."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines influence-t-elle le développement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut augmenter le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les maladies maternelles affectent-elles le fœtus ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies, comme le diabète, peuvent augmenter le risque d'anomalies congénitales."
}
},
{
"@type": "Question",
"name": "Le mode de vie maternel joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme, l'alcool et une mauvaise nutrition sont des facteurs de risque importants."
}
},
{
"@type": "Question",
"name": "Les traitements médicaux peuvent-ils influencer le développement ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent être tératogènes et affecter le développement embryonnaire."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Molecular Biology, Princeton University, Princeton, New Jersey, United States of America.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Laboratory for Stem Cell and Developmental Epigenetics, Department of Development and Regeneration, Katholieke Universiteit Leuven, 3000 Leuven, Belgium.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Laboratory for Stem Cell and Developmental Epigenetics, Department of Development and Regeneration, Katholieke Universiteit Leuven, 3000 Leuven, Belgium.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Department for Molecular Evolution and Development, Centre of Organismal Systems Biology, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria ulrich.technau@univie.ac.at.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Embryology Research Unit, Children's Medical Research Institute, and School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany.
Faculty of Biology, University of Freiburg, Freiburg, Germany.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany.
Faculty of Biology, University of Freiburg, Freiburg, Germany.
Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Renal Division, Department of Medicine, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Renal Division, Department of Medicine, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany. sebastian.arnold@pharmakol.uni-freiburg.de.
Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany. sebastian.arnold@pharmakol.uni-freiburg.de.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Women's Hospital, Institute of Genetics, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Whitehead Institute for Biomedical Research, Cambridge, MA, USA. lehmann@wi.mit.edu.
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. lehmann@wi.mit.edu.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Genetics, University of Toronto, 661 University Avenue, Toronto, ON M5G 1M1, Canada.
Program in Developmental and Stem Cell Biology, Research Institute, Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Publications dans "Feuillets embryonnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Genetics, University of Toronto, 661 University Avenue, Toronto, ON M5G 1M1, Canada.
Publications dans "Feuillets embryonnaires" :
Despite recent advances in tremor and dystonia classification, it remains difficult to discriminate essential tremor from dystonic tremor as they are similar in appearance and no biomarker exists. Fur...
Essential tremor (ET) is a highly prevalent neurological disease that frequently runs in families. A recent and controversial proposal is to separate ET patients into two distinct groups - ET versus E...
Probands (n = 84 [56 ET-plus and 28 ET]) and their first- and second-degree relatives (n = 182 and 48) enrolled in a genetics study. χ2 and generalized estimating equations (GEE) tested associations b...
χ2 analyses revealed that ET-plus was no more prevalent in relatives of probands diagnosed with ET-plus than in relatives of probands diagnosed with ET, p > 0.05. Restricting relatives to first-degree...
The data demonstrate that ET-plus does not seem to aggregate in families. As such, they do not lend support to the notion that ET-plus is a valid biological construct....
Since the initial description of Essential Tremor (ET), the entity of ET with rest tremor has proven to be a controversial concept. Some authors argued it could be a late manifestation of ET, others s...
Two scales have been developed and validated in English to evaluate the impact of tremor on daily life, namely Quality of life in Essential Tremor Questionnaire (QUEST) and Essential Tremor Embarrassm...
Essential tremor (ET) is characterized by action tremor, although rest tremor may also occur. Despite this, rest tremor has not been studied extensively. A dearth of studies compare the relationship o...
Two-hundred-and-thirteen ET cases underwent detailed neurological examination, including evaluations of rest, simple kinetic, postural, and intention tremors. A movement disorders neurologist assessed...
Sixty-two cases (29.2%) had rest tremor while seated. Fifteen (7.4%) had rest tremor while standing. Among asymmetric tremor pairings, concordant pairings occurred 2-2.7 times more frequently than dis...
Rest tremor often lateralized with other tremor types. These data add to our knowledge of the phenotypic manifestations of ET....
There is some debate on the relationship between essential tremor with rest tremor (rET) and the classic ET syndrome, and only few MRI studies compared ET and rET patients. This study aimed to explore...
Thirty-three ET patients, 30 rET patients and 45 control subjects (HC) were enrolled. Several MR morphometric variables (thickness, surface area, volume, roughness, mean curvature) of brain cortical r...
rET patients showed increased roughness and mean curvature in some fronto-temporal areas compared with HC and ET, and these metrics significantly correlated with cognitive scores. Cortical volume in t...
Our study demonstrated higher cortical involvement in fronto-temporal areas in rET than in ET patients, which may be linked to the cognitive status. A machine learning approach based on MR volumetric ...
Adapting to different environments throughout daily activities requires flexibility in allocating attention. Compromised dual-tasking can hinder mobility, increase fall risk, and decrease functional i...
There are myths and misperceptions about most human diseases, and neurological diseases are no exception. In many instances, myths and misconceptions reflect what is no more than the collective failur...
Essential tremor (ET), one of the most common neurological disorders, has a phenotypically heterogeneous presentation characterized by bilateral kinetic tremor of the arms and, in some patients, tremo...
We analyzed whole genome sequence data (WGS) generated on 104 multi-generational white families with European ancestry affected by ET. Genome-wide parametric linkage and association scans were analyze...
Parametric linkage analysis of common variants identified several loci with significant evidence of linkage (HLOD ≥3.6). Among the gene regions within the strongest ET linkage peaks were BTC (4q13.3, ...
Linkage and association analyses of WGS identified several novel ET candidate genes, which are implicated in four major pathways that include 1) the epidermal growth factor receptor-phosphatidylinosit...
National Institutes of Health, NINDS, NS073872 (USA) and NIA AG058131(USA)....
Essential tremor (ET) is the most common movement disorder in adults and is considered to be highly heritable. A reduction of the tremor amplitude after alcohol consumption is reported in approximatel...
We recruited families with at least three trembling family members and confirmed ET diagnoses. During the in-hospital alcohol responsivity test, tremor was measured using Archimedes spirals before alc...
Twenty-four confirmed ET patients were included for analysis. The median ASR at T0 (5.0) and T2 (4.75) were significantly higher than the median ASR at T1 (3.25) (both p < 0.001). In 67% of patients, ...
We confirmed that the alcohol responsiveness test of Knudsen et al. is useful in determining objective alcohol responsivity. We established a significantly reduced ASR after alcohol consumption in 67%...
The test designed by Knudsen et al. effectively established objective alcohol responsiveness outside its original research group.We found an objective alcohol response in 67% of our familial ET cohort...